Interested Parties and Potential Investors
From time to time investment opportunities may be available to support capitalization needs of the development of
the patent for our novel cancer treatment method. When investment products are offered, very favorable terms are extended
to investors. Investment is not always open and no public offering is made. Interested investors are always welcomed
to request full details by addressing written correspondence to:
Stephen B. Cantrell, DDS,
MD
NeoPlas Innovation
2001 Mallory Lane
Suite 103
Franklin, TN 37067
Several investment products may be available with
varying degrees of risk and return potential. The minimum investment amount is $10,000 USD for a product offering excellent
return potential and a no-loss guarantee, and $50,000 for a product with no limit on return and no guarantee against loss.
Individuals, investor groups, and institutions may be considered. International investors may be considered if able
to conduct transactions in the United States. All transactions are subject to applicable law including taxation of income
realized.
Please note that anonymous inquiries will not be honored.
Current Investors
Our active
investors can access a secure page with current information on patent status and other activities. Click below to enter
your access name and private password. The page was most recently updated on 29 March 2021.
The next update is in progress and should be finalized and posted in the next few days or
sooner if there is substantial information to share.
Click here to access Investors' Private Page